{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:51:55Z","timestamp":1768701115046,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,17]]},"DOI":"10.7759\/cureus.101730","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T13:16:02Z","timestamp":1768655762000},"source":"Crossref","is-referenced-by-count":0,"title":["Measurable Residual Disease Assessment in B-Lymphoblastic Leukemia Using 5- and 10-Color Flow Cytometry: An Institutional Experience"],"prefix":"10.7759","author":[{"given":"Anand V","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohandoss","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeetha K","family":"Nayanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jithin","family":"TK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopakumar","family":"KG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.7","article-title":"Minimal residual disease in acute lymphoblastic leukemia","volume":"2010","author":"Campana D","year":"2010","unstructured":"Campana D. Minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2010, 2010:7-12. 10.1182\/asheducation-2010.1.7","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz MJ","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP, et al.. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008, 111:5477-85. 10.1182\/blood-2008-01-132837","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.268","article-title":"Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008","volume":"24","author":"Br\u00fcggemann M","year":"2010","unstructured":"Br\u00fcggemann M, Schrauder A, Raff T, et al.. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010, 24:521-35. 10.1038\/leu.2009.268","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0006","article-title":"Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia","volume":"100","author":"Coustan-Smith E","year":"2002","unstructured":"Coustan-Smith E, Sancho J, Behm FG, et al.. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood. 2002, 100:52-8. 10.1182\/blood-2002-01-0006","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-357-2_8","article-title":"Flow cytometric monitoring of residual disease in acute leukemia","volume":"999","author":"Wood BL","year":"2013","unstructured":"Wood BL. Flow cytometric monitoring of residual disease in acute leukemia. Methods Mol Biol. 2013, 999:123-36. 10.1007\/978-1-62703-357-2_8","journal-title":"Methods Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20430","article-title":"Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible","volume":"74","author":"Dworzak MN","year":"2008","unstructured":"Dworzak MN, Gaipa G, Ratei R, et al.. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible. Cytometry B Clin Cytom. 2008, 74:331-40. 10.1002\/cyto.b.20430","journal-title":"Cytometry B Clin Cytom"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen JJ","year":"2012","unstructured":"van Dongen JJ, Lhermitte L, B\u00f6ttcher S, et al.. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012, 26:1908-75. 10.1038\/leu.2012.120","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina T","year":"2012","unstructured":"Kalina T, Flores-Montero J, van der Velden VH, et al.. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012, 26:1986-2010. 10.1038\/leu.2012.122","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores-Montero J","year":"2017","unstructured":"Flores-Montero J, Sanoja-Flores L, Paiva B, et al.. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017, 31:2094-103. 10.1038\/leu.2017.29","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21101","article-title":"Detection of minimal residual disease in pediatric acute lymphoblastic leukemia","volume":"84","author":"Gaipa G","year":"2013","unstructured":"Gaipa G, Basso G, Biondi A, Campana D. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2013, 84:359-69. 10.1002\/cyto.b.21101","journal-title":"Cytometry B Clin Cytom"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19390","article-title":"Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up","volume":"204","author":"Lebecque B","year":"2024","unstructured":"Lebecque B, Besombes J, Dannus LT, et al.. Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up. Br J Haematol. 2024, 204:1872-81. 10.1111\/bjh.19390","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451483-measurable-residual-disease-assessment-in-b-lymphoblastic-leukemia-using-5--and-10-color-flow-cytometry-an-institutional-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T13:16:03Z","timestamp":1768655763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451483-measurable-residual-disease-assessment-in-b-lymphoblastic-leukemia-using-5--and-10-color-flow-cytometry-an-institutional-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.101730","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,17]]}}}